These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Biliary excretion of diphenylhydantoin in the rat. Time-course studies. Inaba T; Umeda T Drug Metab Dispos; 1975; 3(2):69-73. PubMed ID: 236160 [TBL] [Abstract][Full Text] [Related]
5. Urinary excretion of diphenylhydantoin metabolites in newborn infants. Rane A J Pediatr; 1974 Oct; 85(4):543-5. PubMed ID: 4475101 [TBL] [Abstract][Full Text] [Related]
6. The elimination of phenytoin in man. Eadie MJ; Tyrer JH; Bochner F; Hooper WD Clin Exp Pharmacol Physiol; 1976; 3(3):217-24. PubMed ID: 975617 [TBL] [Abstract][Full Text] [Related]
7. Excretion of phenytoin into semen of rabbits and man. Comparison with plasma levels. Swanson BN; Leger RM; Gordon WP; Lynn RK; Gerber N Drug Metab Dispos; 1978; 6(1):70-4. PubMed ID: 23276 [TBL] [Abstract][Full Text] [Related]
8. Phenytoin metabolism in subjects with long and short plasma half-lives. Glazko AJ; Peterson FE; Chang T; Dill WA; Smith TC; Buchanan RA Ther Drug Monit; 1982; 4(3):281-92. PubMed ID: 7135458 [TBL] [Abstract][Full Text] [Related]
10. Isoniazid-induced inhibition in the biotransformation of [14C] diphenylhydantoin in rat. Buttar HS Res Commun Chem Pathol Pharmacol; 1977 Sep; 18(1):35-57. PubMed ID: 905633 [TBL] [Abstract][Full Text] [Related]
11. Plasma concentrations of 5-(4-hydroxyphenyl)-5-phenylhydantoin in phenytoin-treated patients. Hoppel C; Garle M; Rane A; Sjöqvist F Clin Pharmacol Ther; 1977 Mar; 21(3):294-300. PubMed ID: 837648 [TBL] [Abstract][Full Text] [Related]
13. Phenytoin kinetics during pregnancy and the puerperium. Knott C; Williams CP; Reynolds F Br J Obstet Gynaecol; 1986 Oct; 93(10):1030-7. PubMed ID: 3790462 [TBL] [Abstract][Full Text] [Related]
14. Plasma levels and renal excretion of phenytoin and its metabolites in patients with renal failure. Borgå O; Hoppel C; Odar-Cederlöf I; Garle M Clin Pharmacol Ther; 1979 Sep; 26(3):306-14. PubMed ID: 466924 [TBL] [Abstract][Full Text] [Related]
15. The effect of pregnancy on the biliary excretion of [14C]phenytoin in the rat. Vore M; Soliven E; Blunden M J Pharmacol Exp Ther; 1979 Feb; 208(2):257-62. PubMed ID: 762658 [TBL] [Abstract][Full Text] [Related]
16. Bioavailability and pharmacokinetics of phenytoin during pregnancy. Lander CM; Smith MT; Chalk JB; de Wytt C; Symoniw P; Livingstone I; Eadie MJ Eur J Clin Pharmacol; 1984; 27(1):105-10. PubMed ID: 6489420 [TBL] [Abstract][Full Text] [Related]
17. Hydroxylation of 5,5-diphenylhydantoin (phenytoin) by dog liver microsomes. Butler TC; Dudley KH; Mitchell GN; Johnson D Arch Int Pharmacodyn Ther; 1977 Jul; 228(1):4-9. PubMed ID: 21639 [TBL] [Abstract][Full Text] [Related]
18. Comparative drug elimination in man-diphenylhydantoin and amobarbital. Brien JF; Inaba T; Kalow W Eur J Clin Pharmacol; 1975 Oct; 9(1):79-83. PubMed ID: 1233257 [TBL] [Abstract][Full Text] [Related]
19. Antipyrine disposition in relation to lowered anticonvulsant plasma level during pregnancy. Chiba K; Ishizaki T; Tabuchi T; Wagatsuma T; Nakazawa Y Obstet Gynecol; 1982 Nov; 60(5):620-6. PubMed ID: 6815599 [TBL] [Abstract][Full Text] [Related]
20. Quantitative estimation of catechol/methylcatechol pathways in human phenytoin metabolism. Maguire JH Epilepsia; 1988; 29(6):753-9. PubMed ID: 3191891 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]